(This is just a copy of a Co-Cure post (I corrected a few typos))
[5,000,000 GB pounds = 7,627,791.38 US dollars = 5,537,638.53 EURO; 4,000,000.00 GB pounds = 4,430,118.61 EURO = 6,102,208.33 US dollars]
I don't believe it has been widely highlighted that an extra 702,975 was granted by the UK Medical Research Council (MRC) to the PACE Trial in the last two years.
It is unclear to me what the final cost of the trial is but it seems to be safe to say it is over 4m and may be approaching 5m as there may be extra NHS costs as well.
Back in 2004, in a piece for the Edinburgh MESH Spring 2004 newsletter, Michael Sharpe (one of the principal investigators) said: "The trial will cost nearly four million pounds."
There was no knowledge at that time it would need an extension.
I am appending some information on the cost issue. Don't forget that there are four governmental bodies funding the trial: the Medical Research Council (MRC), the Department of Health (DH), the Department for Work and Pensions (DWP) and the Scottish Chief Scientists' Office (CSO).
I'm not sure I have ever seen how much the Department of Work and Pensions (DWP) is contributing. It is highly unusual that they are giving money at all.
The article,:
"MAGICAL MEDICINE: HOW TO MAKE A DISEASE DISAPPEAR Background to, consideration of, and quotations from the Manuals for the Medical Research Councils PACE Trial of behavioural interventions for Chronic Fatigue Syndrome / Myalgic Encephalomyelitis, together with evidence that such interventions are unlikely to be effective and may even be contra‐indicated"http://meactionuk.org.uk/magical-medicine.htm has plenty of other information on the PACE Trial.
Tom
http://meactionuk.org.uk/magical-medicine.htm
http://www.mrc.ac.uk/ResearchPortfolio/Grant/Record.htm?GrantRef=G0200434&CaseId=1429
http://www.pacetrial.org/docs/participantsnewsletter3.pdf
Costs to the NHS (from early in the 2000s) These were listed in a document posted on the internet called the PACE Trial Identifier
http://listserv.nodak.edu/cgi-bin/wa.exe?A2=ind0404B&L=CO-CURE&P=R3461&I=-3
as
[5,000,000 GB pounds = 7,627,791.38 US dollars = 5,537,638.53 EURO; 4,000,000.00 GB pounds = 4,430,118.61 EURO = 6,102,208.33 US dollars]
I don't believe it has been widely highlighted that an extra 702,975 was granted by the UK Medical Research Council (MRC) to the PACE Trial in the last two years.
It is unclear to me what the final cost of the trial is but it seems to be safe to say it is over 4m and may be approaching 5m as there may be extra NHS costs as well.
Back in 2004, in a piece for the Edinburgh MESH Spring 2004 newsletter, Michael Sharpe (one of the principal investigators) said: "The trial will cost nearly four million pounds."
There was no knowledge at that time it would need an extension.
I am appending some information on the cost issue. Don't forget that there are four governmental bodies funding the trial: the Medical Research Council (MRC), the Department of Health (DH), the Department for Work and Pensions (DWP) and the Scottish Chief Scientists' Office (CSO).
I'm not sure I have ever seen how much the Department of Work and Pensions (DWP) is contributing. It is highly unusual that they are giving money at all.
The article,:
"MAGICAL MEDICINE: HOW TO MAKE A DISEASE DISAPPEAR Background to, consideration of, and quotations from the Manuals for the Medical Research Councils PACE Trial of behavioural interventions for Chronic Fatigue Syndrome / Myalgic Encephalomyelitis, together with evidence that such interventions are unlikely to be effective and may even be contra‐indicated"http://meactionuk.org.uk/magical-medicine.htm has plenty of other information on the PACE Trial.
Tom
http://meactionuk.org.uk/magical-medicine.htm
The cost of the PACE Trial (and cost‐effectiveness)
It is now known that additional funding was granted by the MRC but the cost of the PACE trial to the MRC was originally stated as being 1,921,883.00 and the cost to the NHS as being 1,179,909.00, an initial total of 3,101,792.00 (this figure may exclude the usual 40% add‐on which is awarded with Class I grants moreover, it is known that this figure has increased substantially.
As noted in Section I above, the cost of the PACE Trial is said by Professor Sharpe to have risen to about 4 million :Co‐CureACT:RES:22ndOctober2008), a cost that many people regard as scandalous.
The MRC component consisted of research staff costs (1,097,266.00); Overheads(504,742.00); Equipment, including Actiwatch Plus activity sensors (the use of which was abandoned because Peter White deemed it to oonerous for participants to wear one strapped round an ankle at the end of the trial, but many people believe it was because there would be no objective evidence of improvement shown by the Actiwatch sensors, a finding that would be inconvenient to the Investigators, therefore no objective data were to be collected), computers and software, heart rate monitors, stop watches, 18 audio machines and 3,150 audiotapes (36,360.00); Staff Travel (64,880.00), and Consumables, (218,635.00); this figure includes Action for MEs consultancy costs of 4,312.00. The NHS component consisted of the cost of therapists.
When recruitment to the trial proved to be such a problem, an additional amount of 702,975.00 was granted by the MRC (MRC PACE Trial extension 2009‐2010).
http://www.mrc.ac.uk/ResearchPortfolio/Grant/Record.htm?GrantRef=G0200434&CaseId=1429
The PACE trial; A RCT of CBT, graded exercise, adaptive pacing and usual medical care for the chronic fatigue syndrome
Reference: G0200434
Grant Category: Grant
Status: Live
Start date: 14 Jun 2004
End Date: 13 Sep 2010
Overall value: 2,779,295
Board Portfolio: Late Phase Trials
http://www.pacetrial.org/docs/participantsnewsletter3.pdf
Medical Research Council grants further funds
The Medical Research Council (MRC)
has granted the PACE trial team further
funding to allow the study to continue
recruiting until the end of November 2008. This will allow the team to achieve the aim set out in the protocol of recruiting 600 participants. The ethics committee has also agreed to allow the team to recruit over the 600 mark if possible by this end date.
The trigger to increase time to the trial came when it was noticed that recruitment had begun to slow down. This came about for a number of reasons. One of these was the establishment of the CFS Clinical Network Coordinating Centres
(CNCC) which has allowed greater local
access to services for CFS/ME to participants in England. This has allowed people to seek services closer to home where previously they may have had to travel to a secondary care centre such as those hospitals participating in the PACE trial.
Another possible cause of slowed recruitment may have been as a consequence of the release of the NICE guidelines for CFS/ME. The document detailed the review of previous research for treatments for CFS/ME. This has allowed people to make more informed choices about what treatments they may wish to try based on the available research evidence.
The PACE trial retains a significant role as the largest trial ever for comparison of rehabilitative therapies for CFS/ME and the results will add important new information to the pool of previous studies.
As well as increasing time and funding to PACE, we also increased the number of our centres. As announced in the last newsletter a sixth hospital was invited to join the PACE trial and Bristol Frenchay have been successfully recruiting since April of 2007. We are very excited to able to welcome staff and participants from the South West to take part.
With all of these extensions, the PACE trial is now well on course to achieve the target of 600 participants by the end of November 2008, and the ethics committee have also granted us permission to recruit more by this date if we can.
=========SCOTTISH PARLIAMENT - WRITTEN ANSWER
2 December 2005
Health Department
Janis Hughes (Glasgow Rutherglen) (Lab): To ask the Scottish Executive what funding it has awarded for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) services or research since the CFS/ME short-life working group reported in 2002.
(S2W-20924)
Lewis Macdonald:
NHS Boards are given unified budgets, increased by an average of 7.6% in the current financial year, from which they are expected to meet the costs of services for people with CFS/ME and all other chronic conditions. It is for NHS Boards to decide how their unified budgets should be distributed, based on their assessments of local needs.
The Chief Scientist Office (CSO), within the Scottish Executive Health Department, has responsibility for encouraging and supporting research into health and health care needs in Scotland. CSO is currently contributing 250,000 to the Medical Research Council project 'Pacing, Activity and Cognitive behaviour therapy: a randomised Evaluation (PACE)' which compares different approaches to the clinical management of patients with CFS/ME.
SCOTTISH EXECUTIVE
Costs to the NHS (from early in the 2000s) These were listed in a document posted on the internet called the PACE Trial Identifier
http://listserv.nodak.edu/cgi-bin/wa.exe?A2=ind0404B&L=CO-CURE&P=R3461&I=-3
as
"Costs to the NHS: 1,179,909
Costs of therapists: We have approached our NHS providers for these costs.
We need 7 WTE therapists in the 6 centres: 2.5 WTE of CBT, 2 WTE physiotherapists, and 2.5 WTE OTs. Considering different costs in and out of London, this amounts to 241,424 p.a. over 4.5 years (including 6 months training), a total of 1,086,359. Service costs amount to 93,550. Total:
1,179,909."